Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
about
Expecting to eat: glucagon-like peptide-1 and the anticipation of meals.Meal-anticipatory glucagon-like peptide-1 secretion in rats.Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous systemInitial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans.Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats.B-cell translocation gene 2 positively regulates GLP-1-stimulated insulin secretion via induction of PDX-1 in pancreatic β-cells.Central control of body weight and appetite.Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipientsIntestinal hormones and regulation of satiety: the case for CCK, GLP-1, PYY, and Apo A-IV.The effects of GLP-1 analogues on pre-diabetes of the children.Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options.The use of reinforcement learning algorithms to meet the challenges of an artificial pancreas.Commonality between diabetes and Alzheimer's disease and a new strategy for the therapyNovel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations.Taking aim at islet hormones with GLP-1: is insulin or glucagon the better target?Role of glucagon-like peptide-1 analogues on insulin receptor regulation in diabetic rat hearts.GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats.Hedgehog signals inhibit postnatal beta cell neogenesis from adult rat exocrine pancreas in vitro.Central Nervous System GLP-1 Receptors Regulate Islet Hormone Secretion and Glucose Homeostasis in Male Rats.The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model
P2860
Q33634379-12CBB24D-F77B-4577-8095-79F25529BBAAQ33634407-3FFBD223-4F89-4732-9F17-1F7AC28321ABQ33789529-65003094-5224-4EBB-9B89-4BCE8A82862BQ33840311-7457E661-3D84-4526-96DB-9C09018E8216Q34225924-FE8E5768-B2E0-4A94-A803-F05BFDB7808DQ35563969-F8D64B9F-E44F-4DCB-8605-DFB4E74FF226Q35757217-A5179CE1-8C28-454F-96FF-FE2A9CF7B03AQ36907211-8B9D653E-877C-4EF7-9989-54E3B06D76BDQ36979763-E01BEC3C-AA90-467D-9ECC-F867941CDB91Q37072675-8C495A88-AE63-42D3-B72D-DDBE7B3D47C0Q37254771-0C687B0C-61C6-4038-A97B-6C0C0A142D9AQ37734567-3E13AE8D-7CFC-4504-A247-BDADD2A017C8Q37762321-DF0EF76E-433E-48F1-BB65-B406A70974ACQ38131064-C2741ACE-A034-45C1-98C8-A4241344E1B0Q38253931-011C6749-28CC-42EF-A6B0-3D5152A85C9DQ38398676-EA6E0F32-7779-4BD1-90A0-7140FA876BA4Q41279499-1BCEE101-A73A-4416-A254-4EEF4A72A83FQ43174358-6B77A54D-288B-4B06-B4E2-2D42C2F9BBC0Q45242151-4FAB1808-EAD4-4586-A460-ADDC378B135BQ46469670-FC2F9CC7-2EE6-4336-B29E-65DF2068DCC0Q51041822-2B77AB89-2DB2-4756-8FA4-751813F952FBQ58447913-F949441E-DBA3-467F-834C-21FF600F0F8D
P2860
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
@ast
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
@en
type
label
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
@ast
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
@en
prefLabel
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
@ast
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
@en
P2860
P1476
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
@en
P2093
David A D'Alessio
Torsten P Vahl
P2860
P304
P356
10.1152/AJPENDO.00014.2004
P577
2004-06-01T00:00:00Z